133 related articles for article (PubMed ID: 25212541)
21. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
[TBL] [Abstract][Full Text] [Related]
22. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
[TBL] [Abstract][Full Text] [Related]
23. Eliciting patients' preferences for epilepsy diagnostics: a discrete choice experiment.
Wijnen BF; de Kinderen RJ; Colon AJ; Dirksen CD; Essers BA; Hiligsmann M; Leijten FS; Ossenblok PP; Evers SM
Epilepsy Behav; 2014 Feb; 31():102-9. PubMed ID: 24389020
[TBL] [Abstract][Full Text] [Related]
24. Tailoring chemotherapy supply according to patients' preferences: a quantitative method in colorectal cancer care.
Rosato R; Di Cuonzo D; Ritorto G; Fanchini L; Bustreo S; Racca P; Pagano E
Curr Med Res Opin; 2020 Jan; 36(1):73-81. PubMed ID: 31535573
[No Abstract] [Full Text] [Related]
25. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines.
Gore PR; Madhavan S
J Clin Pharm Ther; 1994 Feb; 19(1):17-25. PubMed ID: 8188784
[TBL] [Abstract][Full Text] [Related]
26. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types.
Feng Z; Meng J; Sun Y; Xie T; Lu W; Wang G; Geng J
BMJ Open; 2023 Jun; 13(6):e072469. PubMed ID: 37270199
[TBL] [Abstract][Full Text] [Related]
27. A discrete-choice experiment to assess treatment modality preferences of patients with depression.
Lokkerbol J; Geomini A; van Voorthuijsen J; van Straten A; Tiemens B; Smit F; Risseeuw A; Hiligsmann M
J Med Econ; 2019 Feb; 22(2):178-186. PubMed ID: 30501437
[TBL] [Abstract][Full Text] [Related]
28. Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions.
Keshishian F; Colodny N; Boone RT
Patient Educ Couns; 2008 May; 71(2):265-84. PubMed ID: 18308499
[TBL] [Abstract][Full Text] [Related]
29. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
Puspitasari HP; Aslani P; Krass I
Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
[TBL] [Abstract][Full Text] [Related]
30. What Characteristics of Nursing Homes Are Most Valued by Consumers? A Discrete Choice Experiment with Residents and Family Members.
Milte R; Ratcliffe J; Chen G; Crotty M
Value Health; 2018 Jul; 21(7):843-849. PubMed ID: 30005757
[TBL] [Abstract][Full Text] [Related]
31. Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients.
Tanaka K; Tachi T; Hori A; Osawa T; Nagaya K; Makino T; Inoue S; Yasuda M; Mizui T; Nakada T; Goto C; Teramachi H
Pharmazie; 2019 Jul; 74(7):439-442. PubMed ID: 31288902
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit.
Crespo A; Tyszka M
J Oncol Pharm Pract; 2017 Jun; 23(4):243-248. PubMed ID: 26911478
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, prospective study evaluating the impact of the clinical pharmacist-physician counselling on warfarin therapy management in Lebanon.
Choumane NS; Malaeb DN; Malaeb B; Hallit S
BMC Health Serv Res; 2018 Feb; 18(1):80. PubMed ID: 29391010
[TBL] [Abstract][Full Text] [Related]
34. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
[TBL] [Abstract][Full Text] [Related]
35. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
[TBL] [Abstract][Full Text] [Related]
36. Patient Preference for Aggressive Medication Therapies with Potentially Stronger Adverse Drug Reactions Revealed Using a Scenario-based Survey.
Iihara N; Ohara E; Nishio T; Muguruma H; Matsuoka E; Houchi H; Kirino Y
Yakugaku Zasshi; 2017; 137(9):1161-1167. PubMed ID: 28867703
[TBL] [Abstract][Full Text] [Related]
37. Combining individual-level discrete choice experiment estimates and costs to inform health care management decisions about customized care: the case of follow-up strategies after breast cancer treatment.
Benning TM; Kimman ML; Dirksen CD; Boersma LJ; Dellaert BG
Value Health; 2012; 15(5):680-9. PubMed ID: 22867777
[TBL] [Abstract][Full Text] [Related]
38. A discrete choice experiment to assess cancer patients' preferences for when and how to make treatment decisions.
Herrmann A; Sanson-Fisher R; Hall A; Wall L; Zdenkowski N; Waller A
Support Care Cancer; 2018 Apr; 26(4):1215-1220. PubMed ID: 29090384
[TBL] [Abstract][Full Text] [Related]
39. Pharmacist-patient communication on use of antidepressants: a simulated patient study in community pharmacy.
Chong WW; Aslani P; Chen TF
Res Social Adm Pharm; 2014; 10(2):419-37. PubMed ID: 23787139
[TBL] [Abstract][Full Text] [Related]
40. Testing a pharmacist-patient relationship quality model among older persons with diabetes.
Worley MM
Res Social Adm Pharm; 2006 Mar; 2(1):1-21. PubMed ID: 17138498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
